MTPConnect, Australia’s Medical Technologies and Pharmaceuticals Industry Innovation Growth Centre, has announced Sue MacLeman as its inaugural CEO.
Ms MacLeman will start her role in April 2016. She has more than 25 years’ experience as a pharmaceutical, biotechnology and medical technology executive with roles in corporate, medical, commercial and business development at Schering-Plough, Amgen and Bristol-Myers Squibb.
MTPConnect, which is The Warren Centre’s neighbour at the University of Sydney’s School of Engineering & IT Building, was established as one of six growth centres under the federal Industry Growth Centres Initiative. It will work to promote and accelerate innovation and entrepreneurship, to identify and remove barriers to success and to deliver sectoral competitiveness, collaboration and productivity.
Dr Bronwyn Evans, MTPConnect chair and The Warren Centre deputy chair, commented:
It is fantastic to have Sue MacLeman as our CEO. Sue will bring her vast experience and leadership to the role and will work closely with our MedTech and Pharma industries, researchers, agencies and associations. The Growth Centre aims to enhance Australia’s successes in commercialising research, streamlining the regulatory system, increasing our sector skills and capability, and accessing the global value chain.”
Professor Archie Johnston, Dean of the Faculty of Engineering and IT, says:
The Growth Centre will allow the university to expand its engagement with medical technology and pharmaceutical companies nationally and internationally.
The Warren Centre looks forward to working with Ms McLeman and Dr Evans at MTPConnect to drive Australian innovation in the areas of medical technologies (MedTech) and pharmaceutical research.